Clin2
NCT06529159Possibly a fitRecruiting

Treating H. pylori with argon plasma during endoscopy

Helicobacter Pylori InfectionHelicobacter PyloriHelicobacter Pylori Gastrointestinal Tract InfectionH. Pylori InfectionH. Pylori Gastrointestinal Disease

Part of Digestive system, Infections clinical trials.

This trial tests a new way to treat H. pylori infection using argon plasma (a kind of energy) during an upper endoscopy. It may help people who haven't yet taken antibiotics for H. pylori and are already having an endoscopy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older
  • You have an untreated H. pylori infection
  • You are scheduled for an upper endoscopy as part of your normal care
  • You have not taken antibiotics or stomach-acid-lowering medicine for H. pylori in the last two weeks
  • You are not pregnant or breastfeeding
  • You do not have serious heart or lung disease, or a history of recent heart attack or uncontrolled high blood pressure

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06200779Not yet recruiting· Phase 4
Tailored vs. standard treatment for H. pylori infection

This trial compares a personalized treatment approach to the standard one for H. pylori infection. If you are scheduled for an upper endoscopy and need biopsies, you may be able to join.

Porto, Porto District
NCT07293910Recruiting· Phase 2
Comparing treatments for H. pylori infection

This trial tests whether a new type of acid-reducing drug (vonoprazan) works better than a common one (proton pump inhibitor) when combined with vitamin D or probiotics to clear H. pylori, a bacteria that can cause stomach problems. If you have H. pylori and haven't been treated for it before, this study may be for you.

Tanta
NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka
NCT05332444Recruiting· Phase 4
Check if stomach-bacteria testing improves rescue treatment for H. pylori

This study compares two ways to treat Helicobacter pylori (H. pylori) infection that didn’t go away with prior therapy. One approach uses test results to guide which medicines to use, and the other uses standard (“empiric”) treatment. The goal is to see which works better and more safely as a rescue plan.

Taipei
NCT05061732Recruiting· Phase 4
Treatment and follow-up study for Helicobacter pylori infection

This trial studies how to eradicate Helicobacter pylori (a germ in the stomach) and monitor follow-up results after treatment. You may be a candidate if you have confirmed infection and have not taken certain stomach medicines or antibiotics recently.

Shanghai, Shanghai Municipality
NCT07104318Not yet recruiting· Phase 3
Personalized treatment for H. pylori infection in veterans

This study compares a treatment plan based on your genes to the standard treatment for H. pylori, a stomach infection that can cause ulcers. The goal is to see which approach works better and has fewer side effects.

San Diego, California

Hear when a new Helicobacter Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.